 Astellas Pharma, Inc. OTCPK:ALPMF Q4 2022 Results Conference Call April 27, 2022 1:00 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, Advocacy and Relations Kenji Yasukawa - President and CEO Bernie Zeiher - Chief Medical Officer Yukio Matsui - Chief Commercial Officer Minoru Kikuoka - CFO Conference Call Participants Hidemaru Yamaguchi - Citigroup Securities Kazuaki Hashiguchi - Daiwa Securities Shinichiro Muraoka - Morgan Stanley Securities Fumiyoshi Sakai - Credit Suisse Securities Motoya Kohtani - Nomura Securities Akinori Ueda - Goldman Sachs Securities Kenji Yasukawa Hello, everyone. Im Kenji Yasukawa from Astellas Pharma, Inc. Thank you very much for joining our FY 2021 financial results announcement meeting out of your very busy schedule today. 